Cite
Höybye C, Beck-Peccoz P, Murray RD, et al. Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults). Pituitary. 2021;24(4):622-629doi: 10.1007/s11102-021-01139-2.
Höybye, C., Beck-Peccoz, P., Murray, R. D., Simsek, S., Stalla, G., Strasburger, C. J., Urosevic, D., Zouater, H., & Johannsson, G. (2021). Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults). Pituitary, 24(4), 622-629. https://doi.org/10.1007/s11102-021-01139-2
Höybye, Charlotte, et al. "Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)." Pituitary vol. 24,4 (2021): 622-629. doi: https://doi.org/10.1007/s11102-021-01139-2
Höybye C, Beck-Peccoz P, Murray RD, Simsek S, Stalla G, Strasburger CJ, Urosevic D, Zouater H, Johannsson G. Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults). Pituitary. 2021 Aug;24(4):622-629. doi: 10.1007/s11102-021-01139-2. Epub 2021 Mar 20. PMID: 33742320; PMCID: PMC8270854.
Copy
Download .nbib